Literature DB >> 22229259

Anabolic steroids and cardiovascular risk.

Peter Angell1, Neil Chester, Danny Green, John Somauroo, Greg Whyte, Keith George.   

Abstract

Recent reports from needle exchange programmes and other public health initiatives have suggested growing use of anabolic steroids (AS) in the UK and other countries. Data indicate that AS use is not confined to body-builders or high-level sportsmen. Use has spread to professionals working in emergency services, casual fitness enthusiasts and subelite sportsmen and women. Although the precise health consequences of AS use is largely undefined, AS use represents a growing public health concern. Data regarding the consequences of AS use on cardiovascular health are limited to case studies and a modest number of small cohort studies. Numerous case studies have linked AS use with a variety of cardiovascular disease (CVD) events or endpoints, including myocardial infarction, stroke and death. Large-scale epidemiological studies to support these links are absent. Consequently, the impact of AS use upon known CVD risk factors has been studied in relatively small, case-series studies. Data relating AS use to elevated blood pressure, altered lipid profiles and ECG abnormalities have been reported, but are often limited in scope, and other studies have often produced equivocal outcomes. The use of AS has been linked to the appearance of concentric left ventricular hypertrophy as well as endothelial dysfunction but the data again remains controversial. The mechanisms responsible for the negative effect of AS on cardiovascular health are poorly understood, especially in humans. Possibilities include direct effects on myocytes and endothelial cells, reduced intracellular Ca2+ levels, increased release of apoptogenic factors, as well as increased collagen crosslinks between myocytes. New data relating AS use to cardiovascular health risks are emerging, as novel technologies are developed (especially in non-invasive imaging) that can assess physiological structure and function. Continued efforts to fully document the cardiovascular health consequences of AS use is important to provide a clear, accurate, public health message to the many groups now using AS for performance and image enhancement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229259     DOI: 10.2165/11598060-000000000-00000

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  115 in total

1.  Cardiac arrest following anaesthetic induction in a world-class bodybuilder.

Authors:  Allison Angelilli; Edward S Katz; Ronald M Goldenberg
Journal:  Acta Cardiol       Date:  2005-08       Impact factor: 1.718

2.  Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder.

Authors:  P B Mark; S Watkins; H J Dargie
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

3.  Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.

Authors:  H A Lane; F Grace; J C Smith; K Morris; J Cockcroft; M F Scanlon; J S Davies
Journal:  Eur J Clin Invest       Date:  2006-07       Impact factor: 4.686

4.  Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders.

Authors:  H Kuipers; J A Wijnen; F Hartgens; S M Willems
Journal:  Int J Sports Med       Date:  1991-08       Impact factor: 3.118

5.  The dire consequences of doping?

Authors:  Michael Evans-Brown; Rob Dawson; Jim McVeigh
Journal:  Lancet       Date:  2008-11-01       Impact factor: 79.321

6.  Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease.

Authors:  B Takase; A Uehata; T Akima; T Nagai; T Nishioka; A Hamabe; K Satomura; F Ohsuzu; A Kurita
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

Review 7.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.

Authors:  Vittorio Fineschi; Irene Riezzo; Fabio Centini; Enrico Silingardi; Manuela Licata; Giovanni Beduschi; Steven B Karch
Journal:  Int J Legal Med       Date:  2005-11-15       Impact factor: 2.686

8.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

9.  The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity.

Authors:  J M Zmuda; M C Fahrenbach; B T Younkin; L L Bausserman; R B Terry; D H Catlin; P D Thompson
Journal:  Metabolism       Date:  1993-04       Impact factor: 8.694

10.  Cardiogenic shock complicating myocardial infarction in a doped athlete.

Authors:  Stefano Lunghetti; Valerio Zacà; Silvia Maffei; Arcangelo Carrera; Rosaria Gaddi; Francesco Diciolla; Massimo Maccherini; Mario Chiavarelli; Sergio Mondillo; Roberto Favilli
Journal:  Acute Card Care       Date:  2009
View more
  17 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 2.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

3.  Trading Health Risks for Glory: A Reformulation of the Goldman Dilemma.

Authors:  Juan Marcos González; F Reed Johnson; Matthew Fedoruk; Joshua Posner; Larry Bowers
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

4.  Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study.

Authors:  Peter J Angell; Tevfik F Ismail; Andrew Jabbour; Gillian Smith; Annette Dahl; Ricardo Wage; Greg Whyte; Daniel J Green; Sanjay Prasad; Keith George
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

5.  Testosterone and secondary hypertension: new pieces to the puzzle.

Authors:  Matthias Barton; Eric R Prossnitz; Matthias R Meyer
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

Review 6.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

Review 7.  Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions.

Authors:  Hugo Falqueto; Jorge L R Júnior; Mauro N O Silvério; Juliano C H Farias; Brad J Schoenfeld; Leandro H Manfredi
Journal:  Rev Endocr Metab Disord       Date:  2021-03-30       Impact factor: 6.514

8.  Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids.

Authors:  Stefan Baumann; Claude Jabbour; Aydin Huseynov; Martin Borggrefe; Dariusch Haghi; Theano Papavassiliu
Journal:  Asian J Sports Med       Date:  2014-11-10

9.  Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes.

Authors:  Farzad Gheshlaghi; Mohammad-Reza Piri-Ardakani; Gholam Reza Masoumi; Mohaddaseh Behjati; Parva Paydar
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

Review 10.  Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.

Authors:  Ilpo Huhtaniemi
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.